|
1
|
Danon MJ, Oh SJ, DiMauro S, Manaligod JR,
Eastwood A, Naidu S and Schliselfeld LH: Lysosomal glycogen storage
disease with normal acid maltase. Neurology. 31:51–57.
1981.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Nishino I, Fu J, Tanji K, Yamada T,
Shimojo S, Koori T, Mora M, Riggs JE, Oh SJ, Koga Y, et al: Primary
LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and
myopathy (Danon disease). Nature. 406:906–910. 2000.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Tanaka Y, Guhde G, Suter A, Eskelinen EL,
Hartmann D, Lüllmann-Rauch R, Janssen PM, Blanz J, von Figura K and
Saftig P: Accumulation of autophagic vacuoles and cardiomyopathy in
LAMP-2-deficient mice. Nature. 406:902–906. 2000.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Eskelinen E, Illert AL, Tanaka Y,
Schwarzmann G, Blanz J, Von Figura K and Saftig P: Role of LAMP-2
in lysosome biogenesis and autophagy. Mol Biol Cell. 13:3355–3368.
2002.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Arad M: Cardiac Danon disease: Insights
and challenges. Int J Cardiol. 245:211–212. 2017.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Boucek D, Jirikowic J and Taylor M:
Natural history of Danon disease. Genet Med. 13:563–568.
2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Lee JJ, Ishihara K, Notomi S, Efstathiou
NE, Ueta T, Maidana D, Chen X, Iesato Y, Caligiana A and Vavvas DG:
Lysosome-associated membrane protein-2 deficiency increases the
risk of reactive oxygen species-induced ferroptosis in retinal
pigment epithelial cells. Biochem Biophys Res Commun. 521:414–419.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Thompson DA, Constable PA, Liasis A,
Walters B and Esteban MT: The Physiology of the retinal pigment
epithelium in Danon disease. Retina. 36:629–638. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Brambatti M, Caspi O, Maolo A, Koshi E,
Greenberg B, Taylor MRG and Adler ED: Danon disease: Gender
differences in presentation and outcomes. Int J Cardiol. 286:92–98.
2019.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Sweet ME, Mestroni L and Taylor MRG:
Genetic infiltrative cardiomyopathies. Heart Fail Clin. 14:215–224.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Wang L, Zuo L, Hu J, Shao H, Lei C, Qi W,
Liu Y, Miao Y, Ma X, Huang CL, et al: Dual LQT1 and HCM phenotypes
associated with tetrad heterozygous mutations in KCNQ1, MYH7,
MYLK2, and TMEM70 genes in a three-generation Chinese family.
Europace. 18:602–609. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Authors/Task Force members, Elliott PM,
Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, Hagege
AA, Lafont A, Limongelli G, et al: 2014 ESC Guidelines on diagnosis
and management of hypertrophic cardiomyopathy: The task force for
the diagnosis and management of hypertrophic cardiomyopathy of the
European Society of Cardiology (ESC). Eur Heart J. 35:2733–2779.
2014.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Sokolow M and Lyon TP: The ventricular
complex in left ventricular hypertrophy as obtained by unipolar
precordial and limb leads. Am Heart J. 37:161–186. 1949.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lang RM, Badano LP, Mor-Avi V, Afilalo J,
Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA,
Kuznetsova T, et al: Recommendations for cardiac chamber
quantification by echocardiography in adults: An update from the
American Society of Echocardiography and the European Association
of Cardiovascular Imaging. J Am Soc Echocardiogr. 281–39.
(e14)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Nagueh SF, Appleton CP, Gillebert TC,
Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka
PA and Evangelista A: Recommendations for the evaluation of left
ventricular diastolic function by echocardiography. J Am Soc
Echocardiogr. 22:107–133. 2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Martin D, Arthur C, Richard G, Levin RI;
Criteria Committee, Devereaux RP, et al: Nomenclature and Criteria
for Diagnosis of Diseases of Heart and great vessels. 9th edition.
Little Brown, Boston, MA. 1994.
|
|
17
|
Gourzi P, Pantou MP, Gkouziouta A,
Kaklamanis L, Tsiapras D, Zygouri C, Constantoulakis P, Adamopoulos
S and Degiannis D: A new phenotype of severe dilated cardiomyopathy
associated with a mutation in the LAMP2 gene previously known to
cause hypertrophic cardiomyopathy in the context of Danon disease.
Eur J Med Genet. 62:77–80. 2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Yang Z, McMahon CJ, Smith LR, Bersola J,
Adesina AM, Breinholt JP, Kearney DL, Dreyer WJ, Denfield SW, Price
JF, et al: Danon disease as an underrecognized cause of
hypertrophic cardiomyopathy in children. Circulation.
112:1612–1617. 2005.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Charron P, Villard E, Sébillon P, Laforêt
P, Maisonobe T, Duboscq-Bidot L, Romero N, Drouin-Garraud V,
Frébourg T, Richard P, et al: Danon's disease as a cause of
hypertrophic cardiomyopathy: A systematic survey. Heart.
90:842–846. 2004.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Arad M, Maron BJ, Gorham JM, Johnson WH
Jr, Saul JP, Perez-Atayde AR, Spirito P, Wright GB, Kanter RJ,
Seidman CE and Seidman JG: Glycogen storage diseases presenting as
hypertrophic cardiomyopathy. N Engl J Med. 352:362–372.
2005.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Cheng Z, Cui Q, Tian Z, Xie H, Chen L,
Fang L, Zhu K and Fang Q: Danon disease as a cause of concentric
left ventricular hypertrophy in patients who underwent
endomyocardial biopsy. Eur Heart J. 33:649–656. 2012.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Liu Y, Chen X, Wang F, Liang Y, Deng H,
Liao H, Zhang Q, Zhang B, Zhan X, Fang X, et al: Prevalence and
clinical characteristics of Danon disease among patients with left
ventricular hypertrophy and concomitant electrocardiographic
preexcitation. Mol Genet Genomic Med. 7(e638)2019.PubMed/NCBI View
Article : Google Scholar
|
|
23
|
D'souza RS, Levandowski C, Slavov D, Graw
SL, Allen LA, Adler E, Mestroni L and Taylor MR: Danon disease:
Clinical features, evaluation, and management. Circ Heart Fail.
7:843–849. 2014.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Sugie K, Komaki H, Eura N, Shiota T, Onoue
K, Tsukaguchi H, Minami N, Ogawa M, Kiriyama T, Kataoka H, et al: A
nationwide survey on Danon disease in Japan. Int J Mol Sci.
19(3507)2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Hedberg Oldfors C, Máthé G, Thomson K,
Tulinius M, Karason K, Östman-Smith I and Oldfors A: Early onset
cardiomyopathy in females with Danon disease. Neuromuscul Disord.
25:493–501. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Maron BJ, Roberts WC, Arad M, Haas TS,
Spirito P, Wright GB, Almquist AK, Baffa JM, Saul JP and Ho CY:
Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy.
JAMA. 301:1253–1259. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Miani D, Taylor M, Mestroni L, D'Aurizio
F, Finato N, Fanin M, Brigido S and Proclemer A: Sudden death
associated with Danon disease in women. Am J Cardiol. 109:406–411.
2012.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Dara BS, Rusconi PG and Fishman JE: Danon
disease: Characteristic late gadolinium enhancement pattern on
cardiac magnetic resonance imaging. Cardiol Young. 21:707–709.
2011.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kim H, Cho A, Lim BC, Kim MJ, Kim KJ,
Nishino I, Hwang YS and Chae JH: A 13-year-old girl with proximal
weakness and hypertrophic cardiomyopathy with Danon disease. Muscle
Nerve. 41:879–882. 2010.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Ogura S, Nakamura K, Morita H, Toh N,
Nakagawa K, Yoshida M, Watanabe A, Nishii N, Miyoshi T and Ito H:
New appearance of fragmented QRS as a predictor of ventricular
arrhythmic events in patients with hypertrophic cardiomyopathy.
Circ J. 84:487–494. 2020.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ratheendran AC, Subramanian M, Bhanu DK,
Prabhu MA, Kannan R, Natarajan KU, Saritha Sekhar S, Thachathodiyil
R, Harikrishnan MS and Pai PG: Fragmented QRS on
electrocardiography as a predictor of myocardial scar in patients
with hypertrophic cardiomyopathy. Acta Cardiol. 75:42–46.
2020.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Rattanawong P, Riangwiwat T, Kanitsoraphan
C, Chongsathidkiet P, Kanjanahattakij N, Vutthikraivit W and Chung
EH: Baseline fragmented QRS increases the risk of major arrhythmic
events in hypertrophic cardiomyopathy: Systematic review and
meta-analysis. Ann Noninvasive Electrocardiol.
23(e12533)2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Özyılmaz S, Akgül Ö, Uyarel H, Pusuroğlu
H, Karayakalı M, Gül M, Çetin M, Satılmışoğlu H, Yıldırım A and
Bakır İ: Assessment of the association between the presence of
fragmented QRS and the predicted risk score of suddena cardiac
death at 5 years in patients with hypertrophic cardiomyopathy.
Anatol J Cardiol. 18:54–61. 2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Ma S, Zhang M, Zhang S, Wang J, Zhou X,
Guo G, Wang L, Wang M, Peng Z, Guo C, et al: Characterisation of
Lamp2-deficient rats for potential new animal model of Danon
disease. Sci Rep. 8(6932)2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Xu N, Bei X, Zhou W, He X-Z, Tao H-W and
Liu X: New reference values for echocardiography dimensions of 800
healthy Chinese infants and children. Chinese J Med Ultrasound
(electronic edition). 1:40–49. 2012.PubMed/NCBI View Article : Google Scholar
|
